Teach a Computer to Recognize AML

Researchers have developed the first computer machine-learning model to accurately predict which patients diagnosed with acute myelogenous leukemia, or AML, will go into remission following treatment for their disease and which will relapse. The computer was trained using bone marrow data and medical histories of AML patients, as well as blood data from healthy individuals. Cases about which the computer had no information were evaluated by the algorithm by applying knowledge about similar cases in the database. The computer was then able to predict remission with 100 percent accuracy. Relapse was correctly predicted in 90 percent of relevant cases.

"It's pretty straightforward to teach a computer to recognize AML, once you develop a robust algorithm, and in previous work we did it with almost 100 percent accuracy," said Murat Dundar, senior author of the disease-progression study and associate professor of computer science in the School of Science at Indiana University-Purdue University Indianapolis. "What was challenging was to go beyond that work and teach the computer to accurately predict the direction of change in disease progression in AML patients, interpreting new data to predict the unknown: which new AML patients will go into remission and which will relapse."

"As the input, our computational system employs data from flow cytometry, a widely utilized technology that can rapidly provide detailed characteristics of single cells in samples such as blood or bone marrow," explained Bartek Rajwa, first author of the study and research assistant professor of computational biology in the Bindley Bioscience Center at Purdue University. "Traditionally, the results of flow cytometry analyses are evaluated by highly trained human experts rather than by machine-learning algorithms. But computers are often better at extracting knowledge from complex data than humans are."

Automated measurement and monitoring of response to treatment of AML are critical not only for objective evaluation of disease-status prognosis but also for timely assessment of treatment strategies, the study's authors noted. Their work creates and underlies a clinical decision support system that recognizes the presence of minute residual amounts of malignant cells of any AML type in bone marrow samples, enabling early identification of change in direction of disease progression.

"Machine learning is not about modeling data. It's about extracting knowledge from the data you have so you can build a powerful, intuitive tool that can make predictions about future data that the computer has not previously seen - the machine is learning, not memorizing - and that's what we did," said Dundar, an internationally respected machine-learning scientist who specializes in teaching computers to understand biomedical data.

The National Cancer Institute anticipated that 19,950 individuals would be diagnosed with AML in 2016 and forecast that approximately 10,430 deaths from AML would occur last year.

The study was a collaboration of IUPUI's Dundar and Purdue's Rajwa with Roswell Park Cancer Institute's Paul K. Wallace, a flow cytometry expert, and Elizabeth A. Griffiths, a physician who treats patients with AML.

This research, which has potential application to other hematological neoplasms in addition to AML, was supported by National Science Foundation grant IIS-1252648 (CAREER), by National Institute of Biomedical Imaging and Bioengineering grant 5R21EB015707 and in part by National Cancer Institute grant 5P30 CA01605. The content is solely the responsibility of the authors and does not necessarily represent the official views of NSF and NIH.

Rajwa B, Wallace PK, Griffiths EA, Dundar M.
Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data. IEEE Trans Biomed Eng. 2016 Jul 13. doi: 10.1109/TBME.2016.2590950.

Most Popular Now

New Algorithm can Predict Diabetic Kidne…

Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease...

AI could Improve Heart Attack Diagnosis …

An algorithm developed using artificial intelligence (AI) could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research from...

AI Predicts Future Pancreatic Cancer

An artificial intelligence (AI) tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients’ medical records, according to...

AI Voice Coach Shows Promise in Depressi…

Artificial intelligence (AI) could be a useful tool in mental health treatment, according to the results of a new pilot study led by University of Illinois Chicago researchers. The study...

ChatGPT Passes Radiology Board Exam

The latest version of ChatGPT passed a radiology board-style exam, highlighting the potential of large language models but also revealing limitations that hinder reliability, according to two new research studies...

Scientists develop AI tool to predict Pa…

Scientists from UNSW Sydney with collaborators at Boston University have developed a tool that shows early promise in detecting Parkinson’s disease years before the first symptoms start appearing. In research published...

Better than Humans: AI in Intensive Care…

In the future, artificial intelligence (AI) will play an important role in medicine. In diagnostics, successful tests have already been performed: for example, the computer can learn to categorise images...

Could Online Gaming Social Networks Have…

For millions of Americans playing some type of video game is a daily occurrence. Games can be a welcome form of entertainment and relaxation for many, and the internet can...

Siemens Healthineers Opens State-of-the-…

Siemens Healthineers has opened its new Education & Development Center (EDC) in Erlangen. The open-plan building offers space for the currently 240 trainees and integrated degree program participants in Erlangen...

Siemens Healthineers Invests 80 Million …

Siemens Healthineers is building a new factory in Forchheim for the cultivation of crystals for semiconductor production. The total investment amounts to 80 million euros. The new factory is expected...

Orion Health Welcomes New Sales Director…

Orion Health has appointed a new sales director for Scotland. Gabriel Radford, who has a background in business development for companies working with health, social care, and local government, will...

AI Tool Outperforms Human Emergency Call…

A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers.(1) The framework...